These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 12080053)
1. Specific inhibition of ICAM-1 expression mediated by gene targeting with Triplex-forming oligonucleotides. Besch R; Giovannangeli C; Kammerbauer C; Degitz K J Biol Chem; 2002 Sep; 277(36):32473-9. PubMed ID: 12080053 [TBL] [Abstract][Full Text] [Related]
2. DNA binding and antigene activity of a daunomycin-conjugated triplex-forming oligonucleotide targeting the P2 promoter of the human c-myc gene. Carbone GM; McGuffie E; Napoli S; Flanagan CE; Dembech C; Negri U; Arcamone F; Capobianco ML; Catapano CV Nucleic Acids Res; 2004; 32(8):2396-410. PubMed ID: 15121897 [TBL] [Abstract][Full Text] [Related]
3. Triplex-forming oligonucleotides - sequence-specific DNA ligands as tools for gene inhibition and for modulation of DNA-associated functions. Besch R; Giovannangeli C; Degitz K Curr Drug Targets; 2004 Nov; 5(8):691-703. PubMed ID: 15578950 [TBL] [Abstract][Full Text] [Related]
5. DNA damage produced by 125I-triplex-forming oligonucleotides as a measure of their successful delivery into cell nuclei. Panyutin IV; Sedelnikova OA; Bonner WM; Panyutin IG; Neumann RD Ann N Y Acad Sci; 2005 Nov; 1058():140-50. PubMed ID: 16394133 [TBL] [Abstract][Full Text] [Related]
6. Targeting chromosomal sites with locked nucleic acid-modified triplex-forming oligonucleotides: study of efficiency dependence on DNA nuclear environment. Brunet E; Corgnali M; Cannata F; Perrouault L; Giovannangeli C Nucleic Acids Res; 2006; 34(16):4546-53. PubMed ID: 16951289 [TBL] [Abstract][Full Text] [Related]
7. An efficient antigene activity and antiproliferative effect by targeting the Bcl-2 or survivin gene with triplex forming oligonucleotides containing a W-shaped nucleoside analogue (WNA-βT). Taniguchi Y; Sasaki S Org Biomol Chem; 2012 Oct; 10(41):8336-41. PubMed ID: 22987068 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of T7 RNA polymerase transcription by phosphate and phosphorothioate triplex-forming oligonucleotides targeted to a R.Y site downstream from the promoter. Alunni-Fabbroni M; Manfioletti G; Manzini G; Xodo LE Eur J Biochem; 1994 Dec; 226(3):831-9. PubMed ID: 7813472 [TBL] [Abstract][Full Text] [Related]
9. Triple helix-mediated inhibition of gene expression is increased by PUVA. Besch R; Marschall C; Schuh T; Giovannangeli C; Kammerbauer C; Degitz K J Invest Dermatol; 2004 May; 122(5):1114-20. PubMed ID: 15140212 [TBL] [Abstract][Full Text] [Related]
10. Targeting the human androgen receptor gene with platinated triplex-forming oligonucleotides. Graham MK; Brown TR; Miller PS Biochemistry; 2015 Apr; 54(13):2270-82. PubMed ID: 25768916 [TBL] [Abstract][Full Text] [Related]
11. Ligand-mediated transcription elongation control using triplex-based padlock oligonucleotides. Bello-Roufaï M; Roulon T; Escudé C Chem Biol; 2004 Apr; 11(4):509-16. PubMed ID: 15123245 [TBL] [Abstract][Full Text] [Related]
17. Induction of the chromosomal translocation t(14;18) by targeting the BCL-2 locus with specific binding I-125-labeled triplex-forming oligonucleotides. Dahmen V; Schmitz S; Kriehuber R Mutat Res Genet Toxicol Environ Mutagen; 2017 Nov; 823():58-64. PubMed ID: 28985947 [TBL] [Abstract][Full Text] [Related]
19. Targeted cross-linking of the human beta-globin gene in living cells mediated by a triple helix forming oligonucleotide. Shahid KA; Majumdar A; Alam R; Liu ST; Kuan JY; Sui X; Cuenoud B; Glazer PM; Miller PS; Seidman MM Biochemistry; 2006 Feb; 45(6):1970-8. PubMed ID: 16460044 [TBL] [Abstract][Full Text] [Related]
20. Sequence-specific gene cleavage in intact mammalian cells by 125I-labeled triplex-forming oligonucleotides conjugated with nuclear localization signal peptide. Sedelnikova OA; Karamychev VN; Panyutin IG; Neumann RD Antisense Nucleic Acid Drug Dev; 2002 Feb; 12(1):43-9. PubMed ID: 12022689 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]